Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. MDT
2. SPY
3. ENOV
4. AON
5. BLSM
6. AZN
7. GRMN
8. GPRO
9. INBS
10. PTGX

Go back to Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

Cyclo Therapeutics (CYTH) PT Lowered to $0.95 at Ascendiant Capital

August 26, 2024 5:03 AM EDT

Ascendiant Capital analyst Lucas Ward lowered the price target on Cyclo Therapeutics (NASDAQ: CYTH) to $0.95 (from $2.60) while maintaining a Buy rating.

The analyst comments "Company completes enrollment in phase 3 trial, affirms regulatory timeline: On May 30, the company announced it has completed enrollment for its... More